| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Training > Make Training Accountable to the Bottom Line |
|
Advice You - Make Training Accountable to the Bottom Line
Recently I was asked: "Is it fair that trainers be held responsible for improving employee performance? Although training may be seen on the surface as a "cau According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product se and effect activity" i.e. you train an individual and their performance increases until they reach a certain standard - I think we all really know that a person's learning (an ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in performance standard) is a result of a wider range of systemic influences." Trainers are and should be accountable to the bottom line like everyone else in lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. the organization. The reason why we struggle with this is because of our outdated notion that training is what happens in the classroom. Training is a business solution a here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe nd should be measured like any other business solution. If a company invest time and money to design, develop, and deliver training their should be demonstrated return for the e d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro fort. Classroom training is an event that should only be undertaken because there was clearly identified business need (not training need). Before one dime is spent on th ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc development side of training we should know exactly with the training should produce. Much of the trouble can be linked to using the wrong training measures: number of people i easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi n the class, the number of training days...Our inability to say that we are going to spend $25,000 to train and the gain will be $50,000 -$100,000 is what diminishes our position nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically in the organization. The only reason to train anyone in an organization is so that they deliver more RESULTS. We have to know what we are hoping to improve, increase, or reduce and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ efore taking up the time and spending the money. Training that is tested only in the classroom is of no benefit to the organization. Training that is delivered to gain behaviora ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi changes that can be viewed in the classroom is of no benefit to the organization. The only training that matters is the training that closes the specified performance gap so tha ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a t the business results improve. Before you can impact the bottom line you must define the bottom line. There are two important questions that must be answered: QUESTION dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod #1 - What does the company need more or less of? All companies are looking for the same things like faster processing times, fewer mistakes, less rework, more sales, or cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin less waste. It doesn't matter what job title employees have, their jobs or operations are expected to return more to the company than it takes away. QUESTION #2 - What tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen do employees need to know and do differently in order for the company to realize their goals? If the company needs more sales, teaching your customer service agents to t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ay please and thank or smile while they dial is not enough. The skill that employees need is to listen and solve the customers problem more efficiently. All training should be ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust esigned and delivered to transfer directly to the workplace because that is the only place that it counts. Training will never add value if the focus remains on skill developmen y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products t instead of appropriate skill application. We have to stop teaching people about "communication" and teach them how to communicate differently to improve relationships and busin . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ss results. It's less important that customer service agents know about the role of customer service and don't know how to truly serve customers. There is a chasm of difference elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip between the two. For more information you may want to read: "Easier to Predict the Weather than Training ROI." http://think6results.com/showarticle.php?article=easitopr#beginnin tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Minding Your Own Brand - Do You Love Me?
|